{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:05:25Z","timestamp":1769969125344,"version":"3.49.0"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,10]]},"DOI":"10.18632\/oncotarget.13750","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T23:41:49Z","timestamp":1480808509000},"page":"2850-2862","source":"Crossref","is-referenced-by-count":5,"title":["Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Paula Silva","family":"Felicio","sequence":"first","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matias Eliseo","family":"Melendez","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia Maria Rebolho Batista","family":"Arantes","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia Maria","family":"Kerr","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"},{"name":"Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[{"name":"International Research Center, AC Camargo Cancer Center, S\u00e3o Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca Silveira","family":"Grasel","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Campacci","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"},{"name":"Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Carvalho","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina","family":"de Carvalho","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edenir In\u00eaz","family":"Palmero","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"1","unstructured":"WHO. The world health report 2006: working together for health. 2016."},{"key":"2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1245\/s10434-012-2256-z","article-title":"Hereditary breast cancer: practical pursuit for clinical translation","volume":"19","author":"Lynch","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two decades after BRCA: setting paradigms in personalized cancer care and prevention","volume":"343","author":"Offit","year":"2014","journal-title":"Science"},{"key":"4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.ejhg.5201256","article-title":"Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1\/2 mutations","volume":"12","author":"Bailey-Wilson","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Gronwald, Byrski, Huzarski, Oszurek, Janicka, Szymanska-Pasternak, Gorski, Menkiszak, Rzepka-Gorska, Lubinski. Hereditary breast and ovarian cancer. Hereditary cancer in clinical practice. 2008; 6:88\u201398.","DOI":"10.1186\/1897-4287-6-2-88"},{"key":"6","volume-title":"BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer","author":"Smith","year":"1993"},{"key":"7","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian","volume":"7","author":"Friedenson","year":"2005","journal-title":"MedGenMed"},{"key":"8","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Maglott","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","article-title":"The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine","volume":"133","author":"Cooper","year":"2014","journal-title":"Human Genet"},{"key":"10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2012.05.015","article-title":"Epigenetic inactivation of DNA repair in breast cancer","volume":"342","author":"Georgakilas","year":"2014","journal-title":"Cancer Lett"},{"key":"11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/epi.14.59","article-title":"Epigenetic mechanisms of breast cancer: an update of the current knowledge","volume":"6","author":"Bernard-Gallon","year":"2014","journal-title":"Epigenomics"},{"key":"12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1101\/gr.132662.111","article-title":"Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression","volume":"22","author":"Laird-Offringa","year":"2012","journal-title":"Genome Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2353\/jmoldx.2007.070031","article-title":"The CpG island methylator phenotype in colorectal cancer","volume":"9","author":"Samowitz","year":"2007","journal-title":"J Mol Diagn"},{"key":"14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13148-011-0045-3","article-title":"Role of DNA methylation in head and neck cancer","volume":"2","author":"Dalay","year":"2011","journal-title":"Clin Epigenetics"},{"key":"15","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/bcr2590","article-title":"Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns","volume":"12","author":"Ringner","year":"2010","journal-title":"Breast Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/sj.onc.1207263","article-title":"Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors","volume":"23","author":"Camargo","year":"2004","journal-title":"Oncogene"},{"key":"17","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Herman","year":"2001","journal-title":"Cancer Res"},{"key":"18","first-page":"75ra25","article-title":"Breast cancer methylomes establish an epigenomic foundation for metastasis","volume":"3","author":"Viale","year":"2011","journal-title":"Sci Transl Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-004-7603-8","article-title":"BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles","volume":"91","author":"Richardson","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"20","first-page":"10585","article-title":"Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients","volume":"15","author":"Suktangman","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"21","doi-asserted-by":"crossref","first-page":"e56256","DOI":"10.1371\/journal.pone.0056256","article-title":"Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer","volume":"8","author":"Hou","year":"2013","journal-title":"PLoS One"},{"key":"22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-014-2995-6","article-title":"Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers","volume":"146","author":"Garber","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molonc.2010.04.011","article-title":"Genetic susceptibility to breast cancer","volume":"4","author":"Garcia-Closas","year":"2010","journal-title":"Mol Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"e57581","DOI":"10.1371\/journal.pone.0057581","article-title":"Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil","volume":"8","author":"Soares","year":"2013","journal-title":"PLoS One"},{"key":"25","first-page":"71","article-title":"Pathology of hereditary breast cancer","volume":"34","author":"van Diest","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","article-title":"Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations","volume":"27","author":"Ferrari","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/carcin\/21.9.1761","article-title":"Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens","volume":"21","author":"Futscher","year":"2000","journal-title":"Carcinogenesis"},{"key":"28","first-page":"1","article-title":"The prognostic value of promoter methylation in early stage triple negative breast cancer","volume":"3","author":"Jensen","year":"2014","journal-title":"J Cancer Ther Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10689-009-9240-1","article-title":"Methylation not a frequent \u201csecond hit\u201d in tumors with germline BRCA mutations","volume":"8","author":"Toland","year":"2009","journal-title":"Fam Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/bjc.2013.144","article-title":"Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers","volume":"108","author":"Nederlof","year":"2013","journal-title":"Br J Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors","volume":"92","author":"Baylin","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ejhg.2011.277","article-title":"MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study","volume":"20","author":"Blanco","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/1471-2407-14-830","article-title":"The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females","volume":"14","author":"Aboussekhra","year":"2014","journal-title":"BMC cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr1522","article-title":"Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer","volume":"8","author":"Eyfjord","year":"2006","journal-title":"Breast Cancer Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/1678-4685-gmb-2014-0364","article-title":"Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital","volume":"39","author":"Mauad","year":"2016","journal-title":"Genet Mol Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjc.6602889","article-title":"A multiplex PCR predictor for aCGH success of FFPE samples","volume":"94","author":"Nederlof","year":"2006","journal-title":"Br J Cancer"},{"key":"37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Barker","year":"2006","journal-title":"Nature genetics"},{"key":"38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Miller","year":"2008","journal-title":"BMC Cancer"},{"key":"39","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Laird","year":"2001","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:56:06Z","timestamp":1594832166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,10]]}},"alternative-id":["13750","27926510"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13750","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}